# GPT 5.2 Review - Round 3/10

**Model:** gpt-5.2-2025-12-11
**Paper:** paper.pdf
**Reasoning effort:** high
**Timestamp:** 2026-01-18T19:05:39.991370
**Response ID:** resp_0cbecdeb42fa051a00696d205556d88193afebf4a5261238ac
**Tokens:** 15562 in / 6070 out
**Response SHA256:** 21185d56b46b9962

---

## Referee Report (Top-field journal standard)

### Summary (what the paper does)
The paper evaluates Montana’s 2023–24 statewide zoning reforms (ADU legalization; duplex legalization in cities above thresholds) using (i) a two-way fixed effects DiD comparing Montana to five “Mountain West” controls and (ii) synthetic control using 47 donor states, with monthly state-level residential building permits (BPS) from Nov 2019–Oct 2025. The DiD point estimate is modestly positive but insignificant (Table 2, p. 19). SCM finds essentially zero average post effect with a very high placebo p-value (Table 5, p. 24–26). The authors appropriately flag pre-trends and conclude identification is not credible with available data (Discussion/Conclusion, pp. 27–31).

For an AER/QJE/Ecta audience, the paper’s central problem is that it does **not** deliver credible causal identification (by the authors’ own admission) and the outcome data are misaligned with the policy margin (ADUs/duplexes). As written, this is not publishable in a top journal.

---

# 1. FORMAT CHECK

**Length**
- Appears to be **~35 pages total** including appendix/figures (Appendix begins p. 35; references around pp. 32–34). Main text likely **>25 pages excluding references/appendix**, so **PASS** on length.

**References**
- The bib includes core DiD papers (Callaway–Sant’Anna; Goodman-Bacon; Sun–Abraham; de Chaisemartin–d’Haultfœuille; Roth et al.), some inference-with-few-clusters papers, and classic housing supply papers.
- However, it is **not adequate** for (i) modern SCM inference/variants, (ii) policy evaluation with single treated unit, (iii) the ADU/upzoning empirical literature, and (iv) within-state/threshold designs directly implied by SB 323. **FAIL (revise)**.

**Prose**
- Major sections are in paragraph form (Intro, Lit, Results, Discussion). **PASS**.

**Section depth**
- Intro (p. 5), Policy background (pp. 6–9), Lit review (pp. 9–12), Methods (pp. 13–17), Results (pp. 18–26), Discussion/Conclusion (pp. 27–31) all have multiple substantive paragraphs. **PASS**.

**Figures**
- Figures shown (Fig. 1 p. 19; Fig. 2 p. 22; Fig. 3 p. 26; Appendix Figs. 4–5 p. 35) have visible plotted data and axes.
- But several are **not publication-quality**: small fonts, crowded legends, and (critically) SCM plots should report **pre-treatment fit diagnostics** more transparently (e.g., RMSPE by period, donor weights table in appendix, and whether outcomes are seasonally adjusted). **Conditional PASS with required upgrades**.

**Tables**
- Tables include real numbers (Tables 1–5). **PASS**.
- Formatting/content issues:
  - Table 1 labels “Total Permits” but numbers look like *monthly average permits* (e.g., 447.4 for Montana pre-period) rather than totals across months. This is confusing and must be corrected (units/definition).  
  - Table 4’s “Treatment: March 2025” result is borderline significant (p=0.059) but should report the **post-period length** and ideally a confidence interval like Table 2.

---

# 2. STATISTICAL METHODOLOGY (CRITICAL)

### (a) Standard errors
- Key regression coefficients report SEs in parentheses (e.g., Table 2, p. 19; Table 3, p. 22; Table 4, p. 23). **PASS**.

### (b) Significance testing
- p-values reported; significance convention noted. Wild cluster bootstrap p-value reported (Table 2). **PASS**.

### (c) Confidence intervals
- 95% CI reported for main DiD (Table 2) and heterogeneity (Table 3). **PASS**.

### (d) Sample sizes
- N reported for regression tables (e.g., Table 2 N=432; Table 3 N=432). **PASS**.
- SCM should also clearly state **T0, pre/post months**, and any donor exclusions due to poor fit (some of this is in Fig. 5 note, p. 35, but it should be in main SCM table).

### (e) DiD with staggered adoption
- There is only one treated unit; no staggered adoption across states, so the canonical TWFE “forbidden comparisons” issue is not the main concern. **PASS on this narrow criterion**.

### (f) RDD requirements
- No RDD is used, so not applicable. However, **the policy design strongly suggests an RDD/threshold strategy** (SB 323’s population cutoffs). The absence of a threshold-based design is a major missed opportunity (see Section 6 below).

### Critical inference concerns despite “PASS” on checklist
Even though inference items are present, the paper’s statistical approach is **not at top-journal standard** because:

1. **Only 6 clusters** in the main DiD (Montana + 5 controls). Wild cluster bootstrap helps, but with one treated cluster, you should also implement **randomization/permutation inference tailored to single treated unit** and/or **Conley–Taber style inference** (you cite Conley & Taber 2011 but do not implement their logic explicitly).  
2. Outcome is **high-frequency noisy** (monthly permits) with strong seasonality and serial correlation. Month-year FE helps, but you should show sensitivity to:
   - alternative aggregation (quarterly),
   - log(permits+1) or Poisson/NegBin count models with exposure,
   - prewhitening or explicit AR structures (at least as robustness).

Bottom line: the paper is not “unpublishable” for missing SEs/p-values—those are present—but it **is** unpublishable because the design does not identify a causal effect credibly (next section).

---

# 3. IDENTIFICATION STRATEGY

### Credibility
- The authors are unusually candid that identification is not credible (Conclusion, pp. 30–31). That candor is good scholarship, but it also means the paper does not clear the bar for a top journal.

Key identification failures:

1. **Parallel trends fails / unstable pre-period**:  
   - Event study shows large and non-uniform pre coefficients (Fig. 2, p. 22; discussion in §5.5). This is not a minor “noise” issue; magnitudes (0 to ~20 permits/100k) are economically large relative to the mean (~39.5).  
2. **Treatment timing is ambiguous** due to the injunction (Dec 2023–Mar 2025). The “treatment” is not a sharp intervention at Jan 2024. Table 4’s alternative timing (Mar 2025) changes results materially, which is a red flag about interpretability.  
3. **State-level aggregation is mismatched to policy exposure**:
   - SB 323 applies only to cities above thresholds (and in certain counties). This is partial/intensity treatment. State-level BPS averages dilute any effect and can easily mask heterogeneous impacts.
4. **Outcome mismeasurement relative to policy**:
   - BPS does not directly identify ADUs; ADUs may appear as 1-unit permits, and duplex legalization is about 2-unit structures. Your “multi-family” bin (2+ units) is too coarse and still does not isolate ADUs. This is classical attenuation plus type-mixing.
5. **Control selection is ad hoc and under-defended**:
   - Five-state Mountain West control group (p. 14) is not justified with a transparent matching procedure. SCM uses 47 states but donor contamination by other reforms is likely and not systematically addressed.

### Placebos/robustness
- SCM placebo distribution is reported (Table 5; Fig. 5). That is good practice.
- But the SCM also has **imperfect pre-fit** (RMSPE ~10, p. 24), which undermines interpretation; you should show sensitivity to:
  - restricting donors to regionally similar states,
  - augmented SCM,
  - leaving-one-out donor robustness,
  - alternative predictor sets and pre-period windows.

### Do conclusions follow?
- The conclusion that “credible identification is not achieved with available data” is consistent with your diagnostics. That said, for a top journal, “we tried and can’t identify” is not a sufficient contribution unless paired with (i) new data enabling better identification or (ii) a methodological breakthrough. Neither is present.

### Limitations
- Limitations are discussed (pp. 29–30) and are largely correct. However, they read as *fatal* rather than *manageable*.

---

# 4. LITERATURE (missing references + BibTeX)

## Methodology you should add (high priority)

1) **Borusyak, Jaravel, Spiess (imputation DiD / event study robustness)**  
Relevant because your event study has pre-trend concerns and you need modern alternatives robust to heterogeneity/noise.
```bibtex
@article{BorusyakJaravelSpiess2021,
  author = {Borusyak, Kirill and Jaravel, Xavier and Spiess, Jann},
  title = {Revisiting Event Study Designs: Robust and Efficient Estimation},
  journal = {arXiv preprint arXiv:2108.12419},
  year = {2021}
}
```
(If you prefer journal versions, cite the latest published version if available; the working paper is widely used.)

2) **Gardner (two-stage DiD / practical guidance)**  
Relevant for improving DiD implementation and diagnostics with few treated units.
```bibtex
@article{Gardner2022,
  author = {Gardner, John},
  title = {Two-Stage Difference-in-Differences},
  journal = {Journal of Econometrics},
  year = {2022},
  volume = {231},
  number = {2},
  pages = {372--408}
}
```

3) **Augmented Synthetic Control (Ben-Michael, Feller, Rothstein)**  
Directly relevant because your SCM pre-fit is imperfect and monthly outcomes are noisy.
```bibtex
@article{BenMichaelFellerRothstein2021,
  author = {Ben-Michael, Eli and Feller, Avi and Rothstein, Jesse},
  title = {The Augmented Synthetic Control Method},
  journal = {Journal of the American Statistical Association},
  year = {2021},
  volume = {116},
  number = {536},
  pages = {1789--1803}
}
```

4) **SCM inference / guidelines (Abadie, Diamond, Hainmueller 2015)**  
You use placebo tests but should cite the formal guidance on inference and fit.
```bibtex
@article{AbadieDiamondHainmueller2015,
  author = {Abadie, Alberto and Diamond, Alexis and Hainmueller, Jens},
  title = {Comparative Politics and the Synthetic Control Method},
  journal = {American Journal of Political Science},
  year = {2015},
  volume = {59},
  number = {2},
  pages = {495--510}
}
```

5) **Interactive fixed effects / generalized synthetic control (Xu 2017; Bai 2009)**  
Relevant because your treated unit’s latent-factor trajectory may differ from controls (pre-trends).
```bibtex
@article{Xu2017,
  author = {Xu, Yiqing},
  title = {Generalized Synthetic Control Method: Causal Inference with Interactive Fixed Effects Models},
  journal = {Political Analysis},
  year = {2017},
  volume = {25},
  number = {1},
  pages = {57--76}
}
```
```bibtex
@article{Bai2009,
  author = {Bai, Jushan},
  title = {Panel Data Models with Interactive Fixed Effects},
  journal = {Econometrica},
  year = {2009},
  volume = {77},
  number = {4},
  pages = {1229--1279}
}
```

## Policy/housing literature you should add (selected)

6) **Freeman & Schuetz (regulation and housing supply; practical constraints)**  
Helps position why zoning reform may not move supply quickly without complementary constraints.
```bibtex
@article{FreemanSchuetz2017,
  author = {Freeman, Lance and Schuetz, Jenny},
  title = {Producing Affordable Housing in Rising Markets: What Works?},
  journal = {Cityscape},
  year = {2017},
  volume = {19},
  number = {1},
  pages = {141--168}
}
```
(If you prefer more directly “zoning reform → permits,” replace with a closer ADU-specific empirical paper—see next.)

7) **Mukhija et al. on ADUs (implementation, barriers, take-up)**  
Your ADU discussion leans heavily on Terner reports; you need peer-reviewed ADU evidence.
```bibtex
@article{MukhijaKhanDasVazquez2015,
  author = {Mukhija, Vinit and Khan, Shahana and Das, Ashok and V{\'a}zquez, Carlos},
  title = {The Costs of Urban Density: Accessory Dwelling Units and Local Regulation},
  journal = {Journal of the American Planning Association},
  year = {2015},
  volume = {81},
  number = {1},
  pages = {1--12}
}
```
(Verify exact bibliographic details; cite the correct JAPA ADU article(s) by Mukhija and coauthors.)

8) **Upzoning and construction (additional quasi-experimental evidence)**  
You cite Auckland; you should also cite U.S. upzoning/land-use deregulation papers (e.g., Chicago, Seattle, LA, etc.) that use parcel-level or neighborhood-level designs. The exact citations depend on what you compare to; right now the lit review is thin on credible U.S. causal designs.

## Also: donor pool contamination
You exclude CA/OR/ME for “major reforms,” but other states enacted ADU or missing-middle reforms (e.g., WA, VT, CT, UT, CO, MN in various forms). You need either:
- a transparent rule-based donor exclusion list with citations, or
- a treatment-intensity model across states rather than “treated vs untreated.”

---

# 5. WRITING AND PRESENTATION

**Structure/clarity**
- The narrative is clear and logically ordered. Policy background is detailed and helpful (pp. 6–9).
- However, the framing over-promises: calling this the “first empirical evaluation” and emphasizing “Montana Miracle” suggests a strong causal contribution, but the paper ultimately concludes it cannot identify effects. That mismatch will frustrate referees and editors.

**Figures/tables quality**
- Informative but not yet top-journal production quality. Improve readability, add consistent y-axis scales where comparisons matter, and add notes on:
  - seasonal adjustment,
  - whether series are smoothed/aggregated,
  - exact construction of per-capita denominators.

**Terminology/precision**
- Be careful with “statistically insignificant” vs “cannot rule out economically meaningful effects” (Table 2 CI is wide).  
- Tighten measurement language: “permits per 100k” based on fixed 2023 population is not truly per-capita over time.

---

# 6. CONSTRUCTIVE SUGGESTIONS (how to make it publishable/impactful)

To have any chance at AER/QJE/Ecta-level publication, you need **new identification** and likely **new data**. The most promising directions are:

1) **Exploit SB 323’s population thresholds with place-level data**
- SB 323 applies to cities >5,000 (and counties >70,000). This is an invitation to:
  - a **regression discontinuity** or **difference-in-discontinuities** design around the cutoff, *if* you can build a dataset of municipal permits/housing starts.
  - At minimum, a **triple-difference**: MT cities above vs below threshold × post × (MT vs similar cities in nearby states).
- This would directly address the “state aggregation dilutes treatment” critique.

2) **Use the BPS place-level files (or local administrative permit microdata)**
- State-level BPS is too coarse and noisy. Place-level BPS would allow:
  - isolating outcomes for the treated municipalities,
  - excluding non-covered areas,
  - checking heterogeneous responses in high-demand metros (Bozeman, Missoula, Billings, etc.).

3) **Measure ADUs explicitly**
- If possible, collect ADU permits from major municipalities (or scrape permit descriptions) to build the correct outcome.
- Alternatively, use parcel/property datasets (CoreLogic/ATTOM) to detect additions/secondary units, or use assessor data where ADUs are coded.

4) **Model the injunction explicitly**
- Treat Dec 2023–Mar 2025 as a period of partial/uncertain treatment:
  - use an event-study with three regimes (pre / injunction / post-court-resolution),
  - or instrument “effective treatment” with court timing (careful: still one unit).

5) **Upgrade inference for single treated unit**
- Implement **randomization inference** where you reassign “treatment” to donor states and compute DiD/SCM estimands consistently (not only SCM placebo gaps).
- Report sensitivity to donor pool restrictions and pre-period windows.

6) **Shift outcomes beyond permits**
- Permits are an intermediate outcome. For welfare relevance, add:
  - rents (Zillow, ACS, CPI rent indices),
  - prices (FHFA/Case-Shiller where available; Zillow),
  - construction employment,
  - vacancy rates.
Even if these are noisier, triangulating mechanisms can add credibility.

---

# 7. OVERALL ASSESSMENT

### Key strengths
- Important policy question; Montana is a salient case.
- Transparent presentation; appropriate caution about pre-trends and identification (Fig. 2; Discussion/Conclusion).
- Uses both DiD and SCM; includes placebo inference for SCM (Table 5; Fig. 5).

### Critical weaknesses (fatal for top journal)
1. **No credible identification** with the current data/design; pre-trends and treatment ambiguity are severe (Fig. 2; §2.3; §6).  
2. **Outcome misalignment**: state-level BPS does not measure ADUs and only crudely captures duplexes; treatment is partial geographically.  
3. **Control group arbitrariness / donor contamination**: five-state DiD controls are ad hoc; SCM donors likely include partially treated states.  
4. **Contribution gap**: concluding “we can’t identify with available data” is not enough for AER/QJE/Ecta without either new microdata or a methodological advance.

### Specific, highest-return fixes
- Obtain place-level permit data and implement a threshold-based or within-state design around SB 323 applicability; explicitly measure ADUs; then revisit SCM/DiD with stronger identification and inference.

---

## VERDICT: REJECT

The paper is carefully executed given the chosen dataset, but the design and measurement limitations prevent credible causal inference, and the authors’ own diagnostics confirm that identification is not achieved. For a top journal, this is a fundamental flaw requiring a new research design and likely new data rather than incremental revisions.